登录

Tachmed与伦敦大学圣乔治学院合作

Tachmed partners with St George’s, University of London

Digital Health | 2024-04-30 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


Experts in infection control at St George’s, University of London have teamed up with at-home digital healthcare solutions developers, Tachmed, to speed up the development of the company’s new at-home digital diagnostics.Tachmed is currently developing a new diagnostic platform for a range of health conditions, using groundbreaking graphene biosensor technology.

伦敦大学圣乔治分校(St George's)的感染控制专家与家庭数字医疗解决方案开发商Tachmed合作,以加速该公司新的家庭数字诊断的开发。Tachmed目前正在开发一种新的健康状况诊断平台,使用开创性的石墨烯生物传感器技术。

Teaming up with the experts from St George’s, University of London will help accelerate its development.During the four-month collaboration, funded by an Innovate UK Accelerated Knowledge Transfer grant, Dr Henry Staines, senior lecturer in global health at the Institute for Infection & Immunity at St George’s, will provide critical knowledge exchange.

与伦敦大学圣乔治分校的专家合作将有助于加速其发展。在为期四个月的合作期间,由英国创新加速知识转移基金资助,圣乔治感染与免疫研究所全球健康高级讲师亨利·斯坦斯博士将提供重要的知识交流。

This is expected to boost development of the technology by optimising Tachmed’s biosensor, which is required to confirm if a pathogen is present or not within a patient sample.Dr Staines explained to Digital Health: “Essentially this role is about verifying and validating the data generated from this ground-breaking new digital diagnostic platform technology.

预计这将通过优化Tachmed的生物传感器来促进该技术的发展,该传感器需要确认患者样本中是否存在病原体。Staines博士向数字健康解释说:“本质上,这个角色是关于验证和验证这种开创性的新数字诊断平台技术产生的数据。

Our expertise lies in the development of diagnostics, with a focus on infectious diseases. This aligns extremely well with Tachmed’s knowledge and use of digital health and commerce.“In the short term, we are providing our advice and expertise to help Tachmed develop the heart of their novel diagnostics platform, the graphene biosensor, so that it functions above and beyond the levels expected by regulatory bodies.

我们的专业知识在于诊断学的发展,重点是传染病。这与Tachmed对数字健康和商业的了解和使用非常吻合。“短期内,我们将提供建议和专业知识,帮助Tachmed开发其新型诊断平台石墨烯生物传感器的核心,使其功能超出监管机构的预期水平。

Moving forwards, we also aim to help expand the pipeline of diagnostics tests that they can provide.”The partnership will ultimately lead to the creation of at-home diagnostic tests supported by a platform that will automatically send results straight to the patient’s healthcare practitioner, with .

展望未来,我们还旨在帮助扩大他们可以提供的诊断测试管道。”该合作关系最终将导致创建由平台支持的家庭诊断测试,该平台将自动将结果直接发送给患者的医疗保健从业者。

推荐阅读

这一医科大学

思宇MedTech 2024-05-19 00:29

华东医药:旗下3款“重磅进口”医美产品“国内临床”取得新进展

医美部落 2024-05-19 00:04

eGastroenterology:肠炎久不愈,益生元来助力

MedSci 2024-05-19 00:02

Digital Health

156篇

最近内容 查看更多

MHRA推出人工智能医疗设备监管沙盒

2 天前

互联健康技术平台提供商Careology与Evolent Health合作,为美国患者提供护理途径

2 天前

格洛斯特郡医院NHS FT推出DrDoctor患者门户网站

2024-05-15

相关公司查看更多

Tachmed

数字诊断服务提供商

立即沟通

产业链接查看更多

所属赛道

其它诊断设备